Difference between revisions of "United States Antibiogram"

(Gram Positives)
(See Also)
Line 104: Line 104:
 
*'''0''' not effective clinically or <30% susceptible
 
*'''0''' not effective clinically or <30% susceptible
 
*'''blank''' data not available
 
*'''blank''' data not available
 +
 +
{{Clinically Relevant Bacteria}}
 +
 +
{{Clinically Utilized Antibiotics}}
  
 
==See Also==
 
==See Also==

Revision as of 06:45, 8 March 2014

Gram Positives

' Penicillins ' Anti-Staphylocccal Penicillins ' ' Amino-Penicillins ' ' Anti-Pseudomonal Penicillins ' ' Carbapenems ' ' ' ' ' Fluroquinolones ' ' ' ' ' ' 1st G Cephalosporins 2nd G. Cephalosporins ' ' 3rd/4th G. Cephalosporins ' ' ' ' ' ' Oral 1st G. Cephalosporins ' Oral 2nd G. Cephalosporins ' ' Oral 3rd G. Cephalosporins ' ' Aminoglycosides ' ' ' ' Macrolides ' ' Ketolide Tetracyclines ' Glycylcycline Glyco/Lipoclycopeptides ' ' ' ' ' Urinary Agents ' Other ' ' ' ' '
Penicillin G Penicillin V Methicillin Nafcillin/Oxacillin Cloxacillin/Diclox. AMP/Amox Amox/Clav AMP-Sulb Ticarcillin Ticar-Clav Pip-Taxo Piperacillin Doripenem Ertapenem Imipenem Meropenem Aztreonam Ciprofloxacin Ofloxacin Pefloxacin Levofloxacin Moxifloxacin Gemifloxacin Gatifloxacin Cefazolin Cefotetan Cefoxitin Cefuroxime Cefotaxime Cefizoxime CefTRIAXone Ceftobiprole Ceftaroline CefTAZidime Cefepime Cefadroxil Cephalexin Cefaclor/Loracarbef Cefproxil Cefuroxime axetil Cefixime Ceftibuten Cefpodox/Cefdinir/Cefditoren Gentamicin Tobramycin Amikacin Chloramphenicol Clindamycin Erythromycin Azithromycin Clarithromycin Telithromycin Doxycycline Minocycline Tigecycline Vancomycin Teicoplanin Telavancin Fusidic Acid Trimethoprim TMP-SMX Nitrofurantoin Fosfomycin Rifampin Metronidazole Quinupristin dalfoppristin Linezolid Daptomycin Colistimethate
Strep. Group A, B, C, G + + + + + + + + + + + + + + + + 0 +/- +/- 0 + + + + + + + + + + + + + + + + + + + + + + + 0 0 0 + + +/- +/- +/- + +/- + + + + + +/- + + + + 0 + + + 0
Strep. Pneumoniae + + + + + + + + + + + + + + + + 0 +/- +/- 0 + + + + + + + + + + + + + + + + + + + + + +/- + 0 0 0 + + + + + +/- + + + + + + +/- +/- + + + 0 + + + 0
Viridans strep +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- + + + + 0 0 0 + + + + + + + + + + + + + +/- + + + + 0 + + 0 +
Strep. milleri + + + + + + + + + + + + + + + + 0 0 0 + + + +
Enterococcus faecalis + + 0 0 0 + + + +/- +/- + + +/- 0 + +/- 0 ^^ ^^ 0 + + + + 0 0 0 0 0 0 0 + + 0 0 0 0 0 0 0 0 0 0 S S S +/- 0 0 0 0 +/- 0 0 + + + + + + + + + +/- 0 0 + + 0
Enterococcus faecium +/- +/- 0 0 0 + + + +/- +/- +/- +/- 0 0 +/- 0 0 0 0 0 0 +/- +/- +/- S 0 0 +/- 0 0 0 0 0 0 0 + +/- +/- + 0 0 + +/- 0 0 + + + 0
Staph. aureus (MSSA) 0 0 + + + 0 + + 0 + + 0 + + + + 0 + + + + + + + + + + + + + + + + +/- + + + + + + 0 0 + + + + +/- + +/- + + + +/- +/- + + + + + +/- + + + 0 + + + 0
Staph. aureus (MRSA) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +/- +/- +/- 0 0 0 0 0 0 0 + + 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +/- +/- + + + + + +/- + + + 0 + + + 0
Staph. aureus (CA-MRSA) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +/- +/- +/- +/- +/- 0 0 0 0 0 0 0 + + 0 0 0 0 0 0 0 0 0 0 +/- +/- +/- +/- +/- + + + + + + + + + + + 0 + + + 0
Staph. Epidermidis 0 0 + + + 0 0 0 +/- +/- + 0 + + + + 0 + + + + + + + +/- +/- +/- +/- +/- +/- +/- + + +/- +/- +/- +/- +/- +/- +/- 0 0 +/- +/- +/- +/- 0 0 +/- 0 0 0 0 0 + + +/- + + + +/- + 0 + + + 0
C. jeikeium 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 + + + + + 0 0 0 0 + + + 0
L. monocytogenes + 0 0 0 0 + + + + + +/- + + 0 + 0 0 + + + + 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 S S S + + + + + + + + + + + + + + 0 + + +/- 0

Key

  • + usually effective clinically or >60% susceptible
  • +/- clinical trials lacking or 30-60% susceptible
  • 0 not effective clinically or <30% susceptible
  • blank data not available

See Also

Source

Sanford Guide to Antimicrobial Therapy 2010